After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Halozyme Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Halozyme Therapeutics Inc is $8.77B. A total of 4.35 million shares were traded on the day, compared to an average of 1.88M shares.
In the most recent transaction, Connaughton Bernadette sold 2,000 shares of HALO for 75.24 per share on Oct 01 ’25. After the transaction, the Director now owns 44,952 company shares. In a previous transaction on Oct 01 ’25, Helen Torley bought 136,569 shares at 73.34 per share.
Among the insiders who sold shares, LaBrosse Nicole disposed of 2,227 shares on Sep 22 ’25 at a per-share price of $77.95. This resulted in the SVP, CHIEF FINANCIAL OFFICER holding 22,079 shares of HALO after the transaction. In another insider transaction, LaBrosse Nicole sold 20,000 shares at $75.71 per share on Sep 10 ’25. Company shares held by the SVP, CHIEF FINANCIAL OFFICER now total 24,306.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, HALO has a high of $79.50 and a low of $42.01.
As of this writing, HALO has an earnings estimate of $1.61 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $1.68 per share and a lower estimate of $1.48. The company reported an EPS of $1.27 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $2.83, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 3.91.
